A Study to Evaluate the Bioequivalence Between Immediate Release Tablets and Minitablets of Deucravacitinib (BMS-986165), and the Effect of Food and pH on the Drug Levels of the Minitablets in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

April 4, 2025

Study Completion Date

April 4, 2025

Conditions

Healthy Participants

Interventions

DRUG

Deucravacitinib

Specified dose on specified days

DRUG

Famotidine

Specified dose on specified days

Trial Locations (1)

Local Institution - 0001, Austin